Evaluation of iNOS-dependent and independent mechanisms of the microvascular permeability change induced by lipopolysaccharide

British Journal of Pharmacology

Volumn 130, Issue 1, 2000, Pages 90-94

  Fujii, Emiko ^a   Yoshioka, Toshimasa ^a   Ishida, Hiroyasu ^b   Irie, Kaoru ^a   Muraki, Takamura ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Endotoxin tolerance; Inducible nitric oxide synthase (iNOS); iNOS deficient mice; Lipopolysaccharide; Microvascular permeability

Indexed keywords

AMINOGUANIDINE; CORTICOSTERONE; DIPHENHYDRAMINE; DYE; HISTAMINE; ICOSANOID; INDOMETACIN; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; ENZYME DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN;

EID: 0034020398     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703277     Document Type: Article

References (22)

1. FUJII, E., IRIE, K., OGAWA, A., OHBA, K. & MURAKI, T. (1996a). Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol., 297, 257-263.
2. FUJII, E., IRIE, K., UCHIDA, Y., TSUKAHARA, F. & MURAKI, T. (1994). Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmied. Arch. Pharmacol., 350, 361-364.
3. FUJII, E., IRIE, K., UCHIDA, Y., TSUKAHARA, F., OHBA, K., OGAWA, A. & MURAKI, T. (1996b). Tolerance to lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur. J. Pharmacol., 313, 129-134.
4. FUJII, E., WADA, K., IRIE, K. & MURAKI, T. (1997a). Changes in vascular permeability elicited by lipoteichoic acid (LTA) and lipopolysaccharide (LPS) in mouse skin. Jpn. J. Pharmacol., 73 (Suppl. 1): 146P.
5. FUJII, E., WADA, K., IRIE, K., YOSHIOKA, T. & MURAKI, T. (1997b). Role of various inflammatory mediators in lipopolysaccharide (LPS)-induced increase in vascular permeability studied in mouse skins. Inflamm. Res., 46 (Suppl. 3): S252.
6. GRISHAM, M.B., JOURD'HEUIL, D. & WINK, D.A. (1999). Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol., 276 (Suppl. 39): G315-G321.
7. GUNNETT, C.A., CHU, Y., HEISTAD, D.D., LOIHL, A. & FARACI, F.M. (1998). Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase. Am. J. Physiol., 275 (Suppl. 44): H416-H421.
8. IUVONE, T., D'ACQUISTO, F., VAN OSSELAER, N., DI ROSA, M., CARNUCCIO, R. & HERMAN, A.G. (1998). Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-κB. Br. J. Pharmacol., 123, 1325-1330.
9. IUVONE, T., VAN DEN BOSSCHE, R., D'ACQUISTO, F., CARNUCCIO, R. & HERMAN, A.G. (1999). Evidence that mast cell degranulation, histamine and tumour necrosis factor α release occur in LPS-induced plasma leakage in rat skin. Br. J. Pharmacol., 128, 700-704.
10. KAWABATA, A., KURODA, R., NISHIKAWA, H., ASAI, T., KATAOKA, K. & TANEDA, M. (1999). Enhancement of vascular permeability by specific activation of protease-activated receptor-1 in rat hindpaw: a protective role of endogenous and exogenous nitric oxide. Br. J. Pharmacol., 126, 1856-1862.
11. LIAO, W. (1996). Endotoxin: Possible roles in initiation and development of atherosclerosis. J. Lab. Clin. Med., 128, 452-460.
12. MACMICKING, J.D., NATHAN, C., HOM, G., CHATRAIN, N., FLETCHER, D.S., TRUMBAUER, M., STEVENS, K., XIE, Q.-W., SOKOL, K., HUTCHINSON, N., CHEN, H. & MUDGETT, J.S. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641-650.
13. MCCUSKEY, R.S., UBASCHEK, R. & UBASCHEK, B. (1996). The microcirculation during endotoxemia. Cardiovasc. Res., 32, 752-763.
14. MURAKI, T., FUJII, E., OKADA, M., HORIKAWA, H., IRIE, K. & OHBA, K. (1996). Effect of S-ethylisothiourea, a putative inhibitor of inducible nitric oxide synthase, on mouse skin vascular permeability. Jpn. J. Pharmacol., 70, 269-271.
15. MURPHY, K., HAUDEK, S.B., THOMPSON, M. & GIROIR, B.P. (1998). Molecular biology of septic shock. New Horiz., 6, 181-193.
16. 6-(1-iminoethyl)lysine on zymosan-induced plasma extravasation in rat skin. J. Immunol., 159, 383-390.
17. ROTH, J., ASLAN, T., STÖRR, B. & ZEISBERGER, E. (1997). Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-α and IL-6 in guinea pigs. Am. J. Physiol., 273, R1529-R1533.
18. SHIMAZU, R., AKASHI, S., OGATA, H., NAGAI, Y., FUKUDOME, K., MIYAKE, K. & KIMOTO, M. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med., 189, 1777-1782.
19. SZABÓ, C. (1995). Alterations in nitric oxide production in various forms of circulatory shock. New Horiz., 3, 2-32.
20. SZABÓ, C., THIEMERMANN, C., WU, C.-C., PERRETTI, M. & VANE, J.R. (1994). Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Nat. Acad. Sci. USA, 91, 271-275.
21. ULEVITCH, R.J. & TOBIAS, P.S. (1995). Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol., 13, 437-457.
22. YANG, R.-B., MARK, M.R., GRAY, A., HUANG, A., XIE, M.H., ZHANG, M., GODDARD, A., WOOD, W.I., GURNEY, A.L. & GODOWSKI, P.J. (1998). Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature, 395, 284-288.